A study of gabapentin in the treatment of tonic-clonic seizures of alcohol withdrawal syndrome.

Abstract	In this study for thirty (30) patients with alcohol withdrawal syndrome, the response to anticolvusant gabapentin was assessed. Thirty (30) patients with median age of 57.0 years and median body weight of 79.1 kg were treated with gabapentin 3 x 300 mg daily for up 30 days. The preliminary findings of this study suggest that gabapentin is very effective against tonic-clonic seizures in alcohol withdrawal syndrome. Gabapentin was safe and well tolerated. For twenty (20) patients no side effect were observed.
Authors	Avdo Rustembegovic, Emin Sofic, Ismet Tahirović, Zlata Kundurović
Journal	Medicinski arhiv (Med Arh) Vol. 58 Issue 1 Pg. 5-6 ( 2004) Bosnia and Herzegovina
PMID	15017894 (Publication Type: Journal Article)
Chemical References	Acetates Amines Anticonvulsants Cyclohexanecarboxylic Acids gamma-Aminobutyric Acid Gabapentin
Topics	Acetates (therapeutic use) Alcohol Withdrawal Seizures (drug therapy) Amines Anticonvulsants (therapeutic use) Cyclohexanecarboxylic Acids Female Gabapentin Humans Male Middle Aged gamma-Aminobutyric Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!